Loading profile…
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
DBA: N/A
EIN 88-2690798 · Snapshot of IRS recognition, filing currency, financial health, and governance.
Fund the development, research & programs of less toxic therapies for pediatric cancer patients
Principal Officer
Thomas Pierce
Total Revenue
$702K
FY2024
Total Expenses
$941K
FY2024
Net Assets
-$71K
Program Ratio
87.2%
expenses on programs
Employees
1
Volunteers
10
Board Members
10
Voting
9
Independent
8 answers compiled from IRS Form 990, BMF, Pub 78, and the Auto-Revocation List.